Are you Dr. Abrey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 61 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10021Phone+1 646-227-3813- Is this information wrong?
Summary
- Dr. Lauren Abrey, MD is a board certified neurologist in New York, New York. She is currently licensed to practice medicine in New York.
Education & Training
- University of Southern California/LAC+USC Medical CenterResidency, Neurology, 1992 - 1994
- Emory University School of MedicineResidency, Neurology, 1991 - 1992
- Providence HospitalInternship, Internal Medicine, 1990 - 1991
- Georgetown University School of MedicineClass of 1990
Certifications & Licensure
- NY State Medical License 1995 - 2024
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma Start of enrollment: 1998 Sep 01
- Temozolomide in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 1999 Jun 01
- Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsLeveraging external data in the design and analysis of clinical trials in neuro-oncology.Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera, Mei Yin C. Polley, Fahar Merchant, Lauren E. Abrey, Joshua E. Allen, Laura K. Aguilar, Est...> ;The Lancet. Oncology. 2021 Oct 1
- 23 citationsPhase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma.Thomas Kaley, Katherine S. Panageas, Elena Pentsova, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic, Lisa M. DeAngelis, Lauren E. Abrey, Eric C. Holland, Antonio...> ;Annals of Clinical and Translational Neurology. 2020 Apr 1
- 6 citationsPhase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02Huanwen Chen, John G. Kuhn, Kathleen R. Lamborn, Lauren E. Abrey, Lisa M. DeAngelis, Frank S. Lieberman, H. Ian Robins, Susan M. Chang, W. K. Alfred Yung, Jan Drappatz...> ;Neuro-Oncology Advances. 2020 Jan 1
- Join now to see all